Results 251 to 260 of about 16,662 (295)
Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel +12 more
wiley +1 more source
Aspartate aminotransferase-to-platelet ratio index (APRI) for staging of fibrosis in adults with chronic hepatitis C. [PDF]
Dreytser E +5 more
europepmc +1 more source
Abstract Aim Tacrolimus dosing in the early post‐kidney transplant period is challenging due to a narrow therapeutic index and substantial interindividual pharmacokinetic (PK) variability. This study aimed to develop and validate mechanism‐informed machine learning (ML) models to support individualized tacrolimus dosing during this critical period ...
Hui Yu +4 more
wiley +1 more source
Predictive value of hepatic, hematological, and immunological markers and their temporal dynamics in chronic hepatitis B functional cure. [PDF]
Zeng J, Zheng C, Zheng Y, Xue X.
europepmc +1 more source
Could carbonic anhydrase IX predict fetal growth restriction in early onset preeclampsia? [PDF]
Ozgen G, Dincgez B.
europepmc +1 more source
Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database. [PDF]
Ritter TE +10 more
europepmc +1 more source
Evaluation of Human Brucellosis Patients with Post-Treatment Standard Tube Agglutination Test Titers. [PDF]
Benli A, Ceylan AN.
europepmc +1 more source

